Prevention & lipidsSecondary analysis
Global burden of cardiovascular disease attributable to smoking, 1990–2019: an analysis of the 2019 Global Burden of Disease Study
- Secondary analysis of the Global Burden of Disease Study 2019
Authors' conclusion
Smoking-attributed CVD morbidity and mortality are declining globally, but significant variation persists
Study context
- Population
- Global population; Cardiovascular disease (CVD) attributable to smoking (ischaemic heart disease, PAD, stroke, AF and flutter, aortic aneurysm), 1990–2019
- Primary endpoint
- Age-standardized mortality rate (ASMR) and DALY rate (ASDR) per 100 000 of smoking-attributed CVD, with estimated annual percentage change (EAPC)
- Follow-up
- 1990–2019
Primary result
As reported in the abstract
Global ASMR of smoking-attributed CVD · 1990 to 2019
ASMR in 1990
57.16/100 000 (95% UI 54.46-59.97)
ASMR in 2019
33.03/100 000 (95% UI 30.43-35.51)
Estimated annual percentage change (EAPC) in ASMR
−0.42 (95% UI −0.47 to −0.38)
Further findings
ASDR of smoking-attributed CVD · 1990–2019
- ASDR decreased between 1990 and 2019
Death burden of CVD subcategories · 1990–2019
- All CVD subcategories showed a decline in death burden
Burden by sex
- Burden higher in men than in women
ASMR by region and socio-demographic index (SDI) · 2019
- Highest ASMR in Eastern Europe, lowest in Andean Latin America
- ASMR lowest in high SDI regions
Original publication
Global burden of cardiovascular disease attributable to smoking, 1990–2019: an analysis of the 2019 Global Burden of Disease Study. Eur J Prev Cardiol. Published 9 April 2024. doi:10.1093/eurjpc/zwae040
Summarised from the published abstract; every number is checked against it